Immunology researcher secures nearly $4 million NIH grant to advance therapeutic vaccine to help end genital herpesPublished bynews.uci.eduon •1 min readFunding supports an innovative ‘Prime/Pull/Keep’ strategy to achieve long-lasting protection against HSV-2Campus newsAll UC IrvineDirectoryArts & Humanities Arts HumanitiesArtsHumanitiesAthleticsCampus Life Administration StudentsAdministrationStudentsHospitalPublic HealthNursingSchool of MedicineLearn moreShareLegalReport
